Evidence map›Paper›PMID 35994698›Full record

ArticleJournal of cellular physiology2022

Involvement of Bid in the crosstalk between ferroptotic agent-induced ER stress and TRAIL-induced apoptosis.

Jin Hong Kim, Abdo J Najy, Jian Li, Xu Luo, Hyeong-Reh C Kim, Mohammad Haroon Asif Choudry, Yong J Lee

Open access · greenAbstract read
In one paragraph

Article in Journal of cellular physiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. The efficacy of hyperthermia-based multimodal therapy is dependent on gatekeeper protein, BID.International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group · 2025
    Article
  8. Article
  9. Article
  10. Ferroptosis in Toxicology: Present and Future.International journal of molecular sciences · 2025
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. FAS mediates apoptosis, inflammation, and treatment of pathogen infection.Frontiers in cellular and infection microbiology · 2025
    Review
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Jin Hong KimDepartment of Surgery, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Abdo J NajyDepartment of Pathology, Barbara Ann Karmanos Institute, Wayne State University School of Medicine, Detroit, Michigan, USA.
Jian LiEppley Institute for Research in Cancer and Allied Diseases, Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Xu LuoEppley Institute for Research in Cancer and Allied Diseases, Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Hyeong-Reh C KimDepartment of Pathology, Barbara Ann Karmanos Institute, Wayne State University School of Medicine, Detroit, Michigan, USA.
Mohammad Haroon Asif ChoudryDepartment of Surgery, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Yong J LeeDepartment of Surgery, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.ORCID 0000-0001-5914-8489
UPMC Hillman Cancer Center · USUniversity of Nebraska Medical Center · USWayne State University · US

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Jessie Nedrow · 1988 to 2026
$158.0M
PDGF D AND PROSTATE CANCER BONE METASTASISR01CA123362 · NCI · WAYNE STATE UNIVERSITY · PI KIM, HYEONG-REH CHOI · 2010 to 2020
$3.1M
Mechanism of Bax/Bak Activation During ApoptosisR01GM118437 · NIGMS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI LUO, XU · 2017 to 2020
$1.3M
Application of in vivo humanized PDX mouse model and ex vivo organoid model to assess the therapeutic efficacy of combinatorial therapy for pseudomyxoma peritoneiR21CA259243 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LEE, YONG J · 2022 to 2023
$412k
Application of a humanized patient-derived xenograft mouse model to assess the preclinical efficacy of combined chemohyperthermia and chimeric TRAIL treatment in ovarian peritoneal carcinomatosisR03CA245171 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LEE, YONG J · 2020 to 2021
$157k
Targeted hyperthermia in combination with chimeric TRAIL and chemotherapeutic agent treatment for colorectal liver metastasisR03CA212125 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LEE, YONG J · 2017 to 2018
$156k
Bax/Bak activation without direct activator BH3-only proteins in cancer cellsR03CA205496 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI LUO, XU · 2017 to 2018
$151k
NCI NIH HHS P30 CA047904NCI NIH HHS R01 CA123362NCI NIH HHS R03 CA205496NCI NIH HHS R03 CA212125NCI NIH HHS R03 CA245171NCI NIH HHS R21 CA259243NIGMS NIH HHS R01 GM118437
6 · The paper itself

Abstract

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces death receptor-mediated extrinsic apoptosis, specifically in cancer cells, and Bid (BH3-interacting domain death agonist) plays an important role in TRAIL-induced apoptosis. Ferroptosis is a newly defined form of regulated cell death known to be distinct from other forms of cell death. However, our previous studies have shown that ferroptosis shares common pathways with other types of programmed cell death such as apoptosis. In this study, we investigated the role of Bid in the crosstalk between the ferroptotic agent-induced endoplasmic reticulum (ER) stress response and TRAIL-induced apoptosis. When human colorectal carcinoma HCT116 cells were treated with the ferroptosis-inducing agents artesunate and erastin in combination with TRAIL, TRAIL-induced activation of caspase-8 was enhanced, and subsequently, the truncation of Bid was increased. Similar results were observed when ovarian adenocarcinoma OVCAR-3 cells were treated with the ferroptotic agents in combination with TRAIL. Results from studies with Bid mutants reveal that the truncation of Bid and the presence of intact BH3 domains are critical for synergistic apoptosis. Nonfunctional Bid mutants were not able to activate the mitochondria-dependent apoptosis pathway, which is required for the conversion of p19 to p17, the active form of caspase-3. These results indicate that Bid plays a critical role in the crosstalk between the ferroptotic agent-induced ER stress response and TRAIL-induced apoptosis.

Indexed as

ApoptosisOvarian NeoplasmsBH3 Interacting Domain Death Agonist ProteinCaspase 8Cell Line, TumorEndoplasmic Reticulum StressFemaleHumansTNF-Related Apoptosis-Inducing LigandTumor Necrosis Factor-alphaBH3 Interacting Domain Death Agonist ProteinCaspase 8TNF-Related Apoptosis-Inducing LigandTumor Necrosis Factor-alphaapoptosisBidendoplasmic reticulum stressferroptosisTRAIL cytotoxicity

Identifiers

PMID35994698
PMCPMC9691566
OpenAlexW4292974708

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.